OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 50 citing articles:

CYP3A4 and CYP3A5 Genotyping Recommendations
Victoria M. Pratt, Larisa H. Cavallari, Makenzie L. Fulmer, et al.
Journal of Molecular Diagnostics (2023) Vol. 25, Iss. 9, pp. 619-629
Open Access | Times Cited: 38

Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy
Daniel L. Hertz, D. Max Smith, Stuart A. Scott, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 4, pp. 768-779
Open Access | Times Cited: 23

Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology
Sharon P. Shriver, Devon V. Adams, Brittany A. McKelvey, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 10, pp. 1181-1192
Open Access | Times Cited: 13

DPYD Genotyping Recommendations
Victoria M. Pratt, Larisa H. Cavallari, Makenzie L. Fulmer, et al.
Journal of Molecular Diagnostics (2024) Vol. 26, Iss. 10, pp. 851-863
Closed Access | Times Cited: 13

Interrogating Pharmacogenetics Using Next-Generation Sequencing
Yuan Ji, Sherin Shaaban
The Journal of Applied Laboratory Medicine (2024) Vol. 9, Iss. 1, pp. 50-60
Open Access | Times Cited: 4

Editorial: Insights in pharmacogenetics and pharmacogenomics: 2023
José A. G. Agúndez, Elena García‐Martín
Frontiers in Pharmacology (2025) Vol. 15
Open Access

Severe bone marrow aplasia following azathioprine therapy in patients with NUDT15 deficiency: A case series
Navneet Mishra, Naman Bansal, Vandana Arya, et al.
Journal of Hematology and Allied Sciences (2025) Vol. 5, pp. 77-80
Closed Access

TPMT and NUDT15 genotyping, TPMT enzyme activity and metabolite determination for thiopurines therapy: a reference laboratory experience
Sherin Shaaban, Brandon S. Walker, Yuan Ji, et al.
Pharmacogenomics (2025), pp. 1-10
Closed Access

Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease: Observations From Daily Practice
Mila Lovrić, Kristina Dukić, Silvija Čuković‐Čavka, et al.
Therapeutic Drug Monitoring (2025)
Closed Access

Opportunities and Challenges of Population Pharmacogenomics
Yitian Zhou, Yoomi Park, Mahamadou D. Camara, et al.
Annals of Human Genetics (2025)
Open Access

Pharmacogenomics in pediatric oncology patients with solid tumors related to chemotherapy-induced toxicity: a systematic review
Paula Hansson, C Blacker, Hanna Uvdal, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104720-104720
Open Access

Development of an Ancestrally Inclusive Preemptive Pharmacogenetic Testing Panel
Christelle Lteif, Brian E. Gawronski, Emily J. Cicali, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 5
Open Access

Characterization of Reference Materials for CYP3A4 and CYP3A5
Andrea Gaedigk, Erin C. Boone, Amy Turner, et al.
Journal of Molecular Diagnostics (2023) Vol. 25, Iss. 9, pp. 655-664
Closed Access | Times Cited: 10

Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis
Courtney Lenz, Ankita Narang, Chad A. Bousman
Pharmacogenetics and Genomics (2024)
Closed Access | Times Cited: 3

Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients
April Kennedy, Anne M. Griffiths, Aleixo M. Muise, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. 12, pp. 2418-2427
Open Access | Times Cited: 3

Characterization of Reference Materials for TPMT and NUDT15
Victoria M. Pratt, Wendy Y. Wang, Erin C. Boone, et al.
Journal of Molecular Diagnostics (2022) Vol. 24, Iss. 10, pp. 1079-1088
Open Access | Times Cited: 16

Computational pharmacogenotype extraction from clinical next-generation sequencing
Tyler Shugg, Reynold C. Ly, Wilberforce Osei, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7

Characterization of Reference Materials for DPYD
Andrea Gaedigk, Amy Turner, Ann M. Moyer, et al.
Journal of Molecular Diagnostics (2024) Vol. 26, Iss. 10, pp. 864-875
Closed Access | Times Cited: 2

Personalization of thiopurine therapy: Current recommendations and future perspectives
Dunja Urbančič, Flaka Pasha, Alenka Šmid, et al.
Acta Pharmaceutica (2024) Vol. 74, Iss. 3, pp. 355-381
Open Access | Times Cited: 2

Understanding the Biology and Testing Techniques for Pharmacogenomics in Oncology: A Practical Guide for the Clinician
Nury Steuerwald, Sarah Morris, D. Grace Nguyen, et al.
JCO Oncology Practice (2024) Vol. 20, Iss. 11, pp. 1441-1451
Closed Access | Times Cited: 2

Implementation of Integrated Clinical Pharmacogenomics Testing at an Academic Medical Center
Claire E. Knezevic, James M. Stevenson, Jonathan Merran, et al.
The Journal of Applied Laboratory Medicine (2024)
Closed Access | Times Cited: 1

Efficacy and safety of azathioprine in patients with Cronkhite-Canada syndrome: a case series from Peking Union Medical College Hospital
Qiushi Xu, Lixin Jin, C Y Ou, et al.
BMC Pharmacology and Toxicology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1

Advancing Precision Medicine in Paediatrics: Past, present and future
Abdelbaset A. Elzagallaai, Charlotte Barker, Tamorah Lewis, et al.
Cambridge Prisms Precision Medicine (2023) Vol. 1
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top